Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in osteoarthritis with hesperidin targeting potential - Scorecard - MDSpire
Advertisement
Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in osteoarthritis with hesperidin targeting potential
Clinical Scorecard: Multi-Omics Analysis Reveals MSR1 as a Central Gene in Programmed Cell Death and Extracellular Matrix Dynamics in Osteoarthritis with Potential for Hesperidin Targeting
At a Glance
Category
Detail
Condition
Osteoarthritis (OA)
Key Mechanisms
Programmed cell death (PCD) and extracellular matrix (ECM) dynamics
Target Population
Patients with Osteoarthritis
Care Setting
Clinical and research settings
Key Highlights
MSR1 identified as a key gene in OA pathogenesis through multi-omics analysis.
517 genes associated with OA enriched in immune and developmental pathways.
MSR1 expression higher in OA samples than in healthy samples with AUC > 0.7.
Hesperidin identified as a high-affinity MSR1-binding compound.
MSR1 promotes apoptosis and ECM degradation in OA-like chondrocytes.
Guideline-Based Recommendations
Diagnosis
Utilize RNA-seq data and weighted gene co-expression network analysis for OA diagnosis.
Management
Consider hesperidin as a potential therapeutic agent targeting MSR1 in OA.
Monitoring & Follow-up
Monitor MSR1 expression levels in OA patients to assess disease progression.
Risks
Increased MSR1 expression may correlate with enhanced apoptosis and ECM degradation.
Patient & Prescribing Data
Individuals diagnosed with Osteoarthritis
Hesperidin may provide a novel therapeutic approach by targeting MSR1.
Clinical Best Practices
Incorporate multi-omics approaches in OA research for better understanding of disease mechanisms.
Evaluate the role of immune modulation in OA treatment strategies.
